v3.26.3
Summary of Significant Accounting Policies (Tables)
6 Months Ended
Jun. 30, 2026
Summary of Significant Accounting Policies [Abstract]  
Schedule of Equity Measured at Fair Value on a Recurring Basis
    Level 3  
Equity   December 31,
2025
    June 30,
2026
 
Contingent consideration - common stock   $ 1,943,100       1,023,400  
Contingent consideration - warrant     53,388       8,618  
Total equity measured by fair value     1,996,488       1,032,018  
Schedule of Useful Life of Intangible Assets

The useful life of intangible assets has been assessed as follows:

 

Category   Useful Life
Property rights   5 years
Software   5 years
License   5 years
Customer relationships   5 years
IP   5 years
Schedule of Disaggregated Information of Revenues

Revenue

 

    Six Months
Ended
    Six Months
Ended
 
    June 30,     June 30,  
    2025     2026  
      (Unaudited)       (Unaudited)  
Sales of FTTPS   $ 58,194     $ 71,153  
Sales of Medical Auxiliary Supplies     9,313       29,753  
Total revenues   $ 67,507     $ 100,906  
Schedule of Currency Exchange Rates

The following table outlines the currency exchange rates that were used in preparing the consolidated financial statements:

 

      June 30,       June 30,  
      2025       2026  
Period-end spot rate   $ 1 = RMB 7.1636     $ 1=RMB 6.7851  
Average rate   $ 1 = RMB 7.2526     $ 1=RMB 6.8624